Purchase Order 75N91024P00089
- Not listed
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $15,641.00, is for the provision of genomic research and analysis tools, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, and bioinformatics software....
- This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international provider Qiagen N.V. The contract has a total ceiling value of $19,008.00 and a period of performance ending on March 30, 2026. The contract does not have a set-aside designation. Qiagen, LLC will provide a range of products and services to support the NIH's biomedical research, public health, and healthcare programs, including...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $11,333.80 contract is for the delivery of specialized products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis tools, and bioinformatics software. Qiagen...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $10,037.40 contract will provide the NIH with Qiagen's sample and assay technologies to support the agency's biomedical research, public health, and healthcare programs. The contract does not have a set-aside designation. Qiagen has a history of providing a range of products and services to federal...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $11,437.12 contract is for the purchase of QIAGEN KITS & SUPPLIES, which are likely molecular biology products and services used to support NIAID's biomedical research, public health, and healthcare programs. Qiagen is an...
- This is a $17,029.90 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The award does not have a set-aside designation. Qiagen provides a range of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is associated with a larger Qiagen indefinite delivery vehicle that...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The $7,820.97 award supports the provision of Qiagen's products and services, which include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, bioinformatics software, and precision medicine analysis tools. Qiagen has a long history...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $12,332.71 firm fixed-price purchase order is for the delivery of Qiagen's products and services, which likely include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis...
- This is a $33,368.50 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer. The contract is for the provision of DNA isolation kits from November 1, 2024 to September 30, 2025. The award is not associated with a set-aside program. Qiagen has a history of providing a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $22,324.00 contract is for the provision of various products and services to support the NIH's biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, bioinformatics software, and precision medicine analysis. Qiagen has previously held several federal indefinite delivery contracts and blanket purchase agreements with customers such as the Army, Department of Veterans Affairs, and Defense Health Agency to deliver its specialized products and services. This contract does not appear to have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 3/28/24 | |
| Not listed | Not listed | $22.3k | 11/21/23 |